Unknown

Dataset Information

The preclinical efficacy of the novel hypomethylating agent NTX-301 as a monotherapy and in combination with venetoclax in acute myeloid leukemia.


ABSTRACT:

SUBMITTER: Lim B 

PROVIDER: S-EPMC9001641 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature